pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,250 catalysts · 3,086 8k filing · 2,046 grant · 1,007 approval · 1,000 device adverse event · 732 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 57 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: recall×from 2026-01-21×clear all
type
  • 8k filing3,086
  • grant2,046
  • approval1,007
  • device adverse event1,000
  • device 510k732
  • earnings583
device pma
539
  • device recall255
  • recall204
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 19, 2026

    37
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)IGC Pharma, Inc.

    TYLENOL a) 500 MG., 2'S DISPLAY, 50CT; b) COLD & FLU, 25CT/2S; c) COLD & FLU SEVERE, 2PK, 50CT; d) PM, 50CT; e) SINUS SEVERE, 2PK, 50CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LIQUID DAYQUIL 12/8oz — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)GlaxoSmithKline LLC

    EXCEDRIN MIGRAINE 2'S- 25 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Swan, White Clear Alcohol, 50%, 16oz, 12 count — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Personal Care, Vaporizing Chest Rub, 4 oz, 12 count, UPC 048155903319 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Petroleum jelly: a) Vaseline Petroleum Jelly, 1.75, 12CT, UPC: 6001085120946; b) Vaseline Men Cooling Petroleum Jelly, 100ML, 12CT, UPC: 60022141; c) Vaseline Vitamin E, Petroleum Jelly, 100ML, 12CT, UPC: 6001085121028; MEN FRESH PETROLEUM JELLY, 100ML, 12CT, UPC: 60022127; d) Lucky Petroleum Jelly, 6 OZ, 12 PK, UPC: 808829081466;048155903562; e) Lucky Petroleum Jelly, COCOA, 6oz, 12ct, UPC: 808829081572, 048155922150; f) Personal Care, CREAMY PETROLEUM JELLY, 4.5oz, 12CT, UPC: 048155908642; g) Personal Care, CREAMY COCOA PETROLEUM JELLY, 4.5oz, 12CT, UPC: 048155922242; h) SOFTEE, PETROLEUM JELLY, 5oz, 12CT, UPC: 096002007208 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Bayer HealthCare Pharmaceuticals Inc

    Aleve 1's, 60 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    TUMS a) Assorted, 12 Ct.; b) Extra Strength (EX) Assorted Berries, 12-count #1194A *05/27; c)Extra Strength (EX) Assorted Fruit, 12-count, #1194C *03/27 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Balance Labs, Inc.

    MOTRIN 2'S DISP.- 50CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LUCKY ICE, Cool Mouthwash, Alcohol Free, 16.9oz, 12CT, UPC: 808829108989 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Personal Care, Ice Gel, 8oz, 12 count, UPC 048155903463 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)GlaxoSmithKline LLC

    EXCEDRIN 2'S DISP.- 30 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Aphios Corp

    Toothpaste: a) COLGATE, TOOTHPASTE, WHITENING, 2.5oz, 24ct; UPC: 035000511065; b) COLGATE, TOOTHPASTE, Regular, 2.5oz, 24ct, UPC: 035000511058; c) COLGATE, TOOTHPASTE, TRIPLE, 2.5oz, 24ct, UPC: 035000512109; d) COLGATE, TOOTHPASTE, MINT ZING, 24CT, 2.5oz, UPC: 035000744609; COLGATE, MAXFRESH, SPICY FRESH, RED TOOTH PASTE, 72CT, 150G; e) CREST, TOOTHPASTE, 40CT, 8.2OZ, UPC: 037000247081 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 — Reason: Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Viatris Inc

    Deodorant: a) Axe, Body Spray, Wild Spice, 6CT, 150ML, UPC: 600108736469; b) LUCKY MENS STICK DEODORANT, SPRING FRESH, 24CT, 2.5 OZ, UPC: 808829111668; c) LUCKY MENS STICK DEODORANT, FRESH COMFORT, 24CT, 1.6 OZ, UPC: 808829089103; d) LADY DEODORANT, CHERRY BLOSSOSM, 24CT, 1.8oz, UPC: 048155921092; e) AXE, BODY SPRAY, APOLLO, 6CT, 150ML; f) AXE, BODY SPRAY, BLACK, 6CT, 150ML; g) AXE, BODY SPRAY, DARK TEMPTATION, 6CT, 150ML; h) AXE, BODY SPRAY, GOLD, 6CT, 150ML; i) AXE, BODY SPRAY, EXCITE, 6CT, 150ML; j) AXE, BODY SPRAY, ICE CHILL, 6CT, 150ML; k) AXE, BODY SPRAY, MUSK, 6CT, 150ML; l) AXE, DEODORANT SPRAY, ADRENALIN, 6CT, 150ML — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    CHILDREN NYQUIL, COLD&FLU, BERRY, 8oz, 12ct — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Halls Cough Drops a) BAGS, MENTHOL, 12CT; b) BAGS, HONEY LEM, 12CT; c) BAGS, DEFENSE CITRUS, 12CT; d) BAGS, CHERRY, 12CT; e) M. CHERRY, 20 STK; f) BRAZIL, Cherry, 21CT/27.5G; f) LEMON. HONEY, 20CT #1180E; g) LIME FRESH, 20CT, #1182; h) MENTHOL BLUE, 20CT, #1180A; i) BRAZIL, Menthol, 21CT/27.5G, j) M . STRAWBERRY, 20 STK; k) DEFENSE, VITAMIN C, 20CT, #1181 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Kenvue Inc.

    Advil a) Ibuprofen, Dispenser Pack, 2 tablet packets in box containing 50 individual packets, UPC: 305730154895; b) PM, Ibuprofen, Dispenser Pack, 2 Caplet packets in box containing 50 packets, UPC: 305730164559 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    PEPTO BISMOL 32CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Carmex a) jar, 12 count, UPC: 083078123154, 083078113155; b) Tube, PEG, 12 count, UPC: 083078123147, 083078113148 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoEncon Safety Products Co recall (Cls II)

    AQ 120 GFEW, Aquarion Preserved Cartridges (2) 3.7 Gallons each — Reason: cGMP deviations. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LIQUID NYQUIL a) regular, 12/8oz; b) cherry, 12/8oz — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Presence of Particulate Matter. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    NYQUIL COLD & FLU -32CT/2PK — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Claritin, 20 Count, UPC: 655708016305 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoAdvanced Pharmaceutical Technology, Inc. recall (Cls II)Transdermal Delivery Solutions Corp

    TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01 — Reason: Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoAlvogen, Inc recall (Cls II)Alvogen Inc

    Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. — Reason: Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Bayer 2Pk- 25 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Kenvue Inc.

    PEPCID COMPLETE - 25CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    DAYQUIL COLD & FLU, 32CT/2PK — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Alka Seltzer, a) Original, 2 tablets per packet in 58 count box, UPC: 815556020033, 016500514473, b) Plus Cold & Flu, 2 tablets per packet in 36 count box, UPC: 016500594932 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Benadryl, 25'S 2PK Box, UPC 815556020316 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall203d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 — Reason: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026grant203d agoKEYSTONE SYMPOSIA — Cardiometabolism in Health and Disease

    HL grant. $18,100. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Jan 23, 2026grant201d agoEMORY UNIVERSITY — Contribution of cell-specific activity to functional MRIEmory University

    NS grant. $577,611. PI: Shella D Keilholz

    full page →nih reporter ↗
    ›Jan 23, 2026grant201d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Understanding kidney failure in individuals with DiGeorge syndrome

    DK grant. $859,998. PI: ROSEMARY V SAMPOGNA

    full page →nih reporter ↗
    ›Jan 25, 2026grant199d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Ovarian Steroid Mechanisms of Female Cannabis Use: Longitudinal and Experimen...Bedrocan BV

    DA grant. $54,538. PI: Anna Patterson

    full page →nih reporter ↗

    Week of Jan 26, 2026

    13
    ›Jan 26, 2026grant198d agoFLORIDA INTERNATIONAL UNIVERSITY — CRISPR/dCas9-Targeted Histone Demethylation Interplays with DNA Repair to Con...

    NS grant. $1,319,674. PI: Prem P Chapagain

    full page →nih reporter ↗
    ›Jan 26, 2026grant
    ← prev
    page 1 of 45
    next →
    198d ago
    EMORY UNIVERSITY — Neuromodulation of somato-sympathetic postganglionic activity after SCIEmory University

    NS grant. $234,750. PI: SHAWN HOCHMAN

    full page →nih reporter ↗
    ›Jan 27, 2026grant197d agoUNIVERSITY OF MINNESOTA — Testing the role of microbial infections in the development of auto-antibodie...University of Minnesota

    AI grant. $43,914. PI: Adrianna M. Rivera-León

    full page →nih reporter ↗
    ›Jan 27, 2026grant197d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Predicting ASD Outcomes Using Quantitative Movement Metrics in InfancyUniversity of California Los Angeles

    NS grant. $625,859. PI: Rujuta Bhatt Wilson

    full page →nih reporter ↗
    ›Jan 27, 2026grant197d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Understanding how T cell receptor recognition of peptide ligands shapes memor...Albert Einstein College of Medicine

    AI grant. $780,787. PI: Gregoire Stephane Lauvau

    full page →nih reporter ↗
    ›Jan 28, 2026recall196d agoCipla USA, Inc. recall (Cls III)Cipla USA Inc

    Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 — Reason: Failed PH Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 28, 2026recall196d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

    Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07 — Reason: Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 28, 2026recall196d agoGraviti Pharmaceuticals Private Limited recall (Cls II)Graviti Pharmaceuticals Inc

    Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10. — Reason: Presence of Foreign Substance — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 28, 2026recall196d agoSpecialty Process Labs LLC recall (Cls II)

    Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 28, 2026grant196d agoTRUDEAU INSTITUTE, INC. — Optimization of Antitubercular Compounds Against a Novel Mycobacterium tuberc...

    AI grant. $921,320. PI: Michaelle Chojnacki

    full page →nih reporter ↗
    ›Jan 28, 2026grant196d agoSLOAN-KETTERING INST CAN RESEARCH — Chalkophore mediated respiratory oxidase flexibility and M. tuberculosis viru...

    AI grant. $3,178,476. PI: Michael S Glickman

    full page →nih reporter ↗
    ›Jan 28, 2026grant196d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Thermostable measles fusion glycoprotein as a new vaccine strategy

    AI grant. $883,295. PI: Matteo Porotto

    full page →nih reporter ↗
    ›Jan 28, 2026grant196d agoUNIVERSITY OF ROCHESTER — Critical developmental windows and underlying processes in extremely low gest...University of Rochester

    AI grant. $1,042,346. PI: ANDREW W GRIMSON

    full page →nih reporter ↗
    $IGC0.2670+0.41%
    $VTRS16.28-0.91%
    $KVUE18.96-0.37%
    $TEVA36.14+2.21%
    $TEVA36.14+2.21%
    $BLNC
    $KVUE18.96-0.37%
    $LBRX45.52-0.72%